Drug resistance mechanisms

Prediction of side-effects of anti-cancer drugs

From genotype to molecular phenotype by proteomics

Interrupting breast cancer treatment for young women who desire pregnancy

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Treating women with endocrine-resistant HR /HER2 advanced breast cancer

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy

Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer

ASH 2015: Latest in CLL

Genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia

Tosedostat for elderly acute myeloid leukaemia